Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000076

COFO and Secretary sold 10,000 shares at an average $28.60 ($286,044)

  • COFO and Secretary acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COFO and Secretary 2023-05-15 Option exercise +10,000 $5.28 $52,800 538,691 I: show line 1 in the form
Schuth Alexander O. COFO and Secretary 2023-05-15 Sale −9,200 $28.55 $262,660 529,491 I: show line 2 in the form
Schuth Alexander O. COFO and Secretary 2023-05-15 Sale −800 $29.23 $23,384 528,691 I: show line 3 in the form
Open-market sales · 10,000 sh · avg $28.60 · $286,044

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Schuth Alexander O. COFO and Secretary 2023-05-15 Option exercise · Stock Option (right to buy) −10,000 78,937 D: show line 4 in the form
Loading xslF345X04/wf-form4_168435700588836.xml…